一种可注射的酸盐水凝的特性,用于可调节的,局部的免疫疗法药物输送
Siena M Mantooth1, Asher M Hancock1, Peter M Thompson2,3
1Joint Department of Biomedical Engineering, University of North Carolina at Chapel Hill and North Carolina State University, Raleigh, North Carolina 27606, United States.
ACS biomaterials science & engineering
|January 19, 2024
概括
一种基于酸盐的新型水凝 (XCSgel) 通过改善瘤内的药物保留来增强局部免疫疗法. 这种可注射的水凝提供可调节的释放,可能减少副作用并改善癌症治疗结果.
科学领域:
- 生物材料科学 生物材料科学
- 癌症治疗方法 癌症治疗方法
- 药物输送系统 药物输送系统
背景情况:
- 免疫疗法药物的局部递送旨在提高癌症治疗的疗效并减少癌症治疗中的全身毒性.
- 由于高间歇性压力和密集的结构,瘤内治疗药物的保留不佳限制了瘤内注射的有效性.
- 基于水凝的系统有望通过抵抗剪切力和防止过早泄漏来改善局部保留.
研究的目的:
- 开发和描述一种新的,可注射的水凝系统,用于局部免疫治疗.
- 评估开发的水凝的物理化学特性,生物相容性和药物释放动力学.
- 为了证明水凝对同配方免疫疗法药物的受控,持续释放的潜力.
主要方法:
- 使用核磁共振和冷扫描电子显微镜开发和表征一种基于酸盐的水凝 (XCSgel).
- 风病学评估以确定剪切薄化和自我愈合特性.
- 在体外和体内生物相容性研究,其次是药物释放研究,以评估治疗保留和释放概况.
主要成果:
- XCSgel表现出理想的特性,包括可注射性,剪切薄化和自我愈合行为.
- 生物相容性研究证实了XCSgel的无毒性,只有短暂的,轻度至中度的炎症.
- 药物释放研究表明,同配方的免疫治疗药物在几天到几周内以电荷依赖的方式持续释放.
结论:
- XCSgel是一种有前途的可注射水凝,用于局部免疫治疗,可改善药物保持和可调节的药物释放.
- 开发的水凝具有临床相关的特性,如可注射性,生物相容性和可成像性.
- 通过使免疫疗法药物的持续局部输送,XCSgel有可能提高癌症治疗结果.
相关概念视频
Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...


